By Mathym
NanoBrain is based on the ground-breaking concept of using Mac-1, an integrin widely used to assess neuroinflammation, as a translational imaging target in stroke. Our priority aim is to develop a multimodal imaging nanoprobe with optimal properties for in-vivo molecular imaging and a safe profile. The imaging probe is based on Mathym's patented nanoparticle. NanoBrain is thus expected to realize the full potential of molecular imaging, a field still in its infancy, and generate growth of the French diagnostics sector to the common benefit of citizens and industry. This project is funded by the French Research National Agency (grant # ANR-15-CE18-0026-01).
